Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Neurol. doi: /nrneurol

Published byDerek Ryan Modified over 5 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Neurol. doi: /nrneurol"— Presentation transcript:

1 Nat. Rev. Neurol. doi:10.1038/nrneurol.2016.21
Table 3 Infectious risk-minimizing strategies for disease-modifying drugs in multiple sclerosis Hartung, H.-P. et al. (2016) Disease-modifying therapies and infectious risks in multiple sclerosis Nat. Rev. Neurol. doi: /nrneurol

2 Nat. Rev. Neurol. doi:10.1038/nrneurol.2016.21
Table 3 Infectious risk-minimizing strategies for disease-modifying drugs in multiple sclerosis Hartung, H.-P. et al. (2016) Disease-modifying therapies and infectious risks in multiple sclerosis Nat. Rev. Neurol. doi: /nrneurol

Download ppt "Nat. Rev. Neurol. doi: /nrneurol"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Multiplication table. x

Multiplication table. x
Table 3. Number of MS patients/ Year of diagnosis / Current Residence

Table 3. Number of MS patients/ Year of diagnosis / Current Residence
Figure 4 Progression-free survival, according to treatment group

Figure 4 Progression-free survival, according to treatment group
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
MRI and possible differentiating features with nonconventional MRI

MRI and possible differentiating features with nonconventional MRI
Figure 1 Perivenous distribution of multiple sclerosis lesions

Figure 1 Perivenous distribution of multiple sclerosis lesions
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Figure 4 Time course of the development of physiological changes

Figure 4 Time course of the development of physiological changes
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Figure 4 Host damage from infection-related inflammatory

Figure 4 Host damage from infection-related inflammatory
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Overview of risk factors for Parkinson disease dementia

Figure 2 Overview of risk factors for Parkinson disease dementia
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Similar presentations

Ads by Google